| 标题 |
[高分]
Abstract CT157: Phase 1 dose-escalation study of linclatamig, a LY6G6D×CD3 T cell-engaging bispecific antibody, in patients with colorectal cancer |
| 网址 | |
| DOI |
10.1158/1538-7445.am2025-ct157
doi
|
| 其它 |
期刊:Cancer Research 作者:M. Fakih; Jayesh Desai; I. Baraibar; I. Melero; D. Spigel; et al 出版日期:2025-04-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)